Biolinq External Interferent Protocol

Clinical trial NCT06560177 · COMPLETED

Trial details

NCT number: NCT06560177
Sponsor: Biolinq Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetes Diabetes Mellitus

Start date: 2024-09-10
Primary completion: 2024-09-27
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.